Dr. Padzur is certainly old guard, he talks a good game about changing, but I don't know that the record shows that it's happened.
As for BP's blocking DCVax-L, they'd be foolish to do so as it only enhances what their therapeutics are capable of. They should sell more, not less, product because of DCVax-L. People living longer will use more of their products, how is this a loss for them.
Gary